Deuterated morpholinyl compounds

Details for Australian Patent Application No. 2008242703 (hide)

Owner Concert Pharmaceuticals Inc.

Inventors Harbeson, Scott L.; Persichetti, Rose A.

Agent Spruson & Ferguson

Pub. Number AU-B-2008242703

PCT Pub. Number WO2008/131259

Priority 60/912,807 19.04.07 US

Filing date 18 April 2008

Wipo publication date 30 October 2008

Acceptance publication date 18 August 2011

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/131259 Priority application(s): WO2008/131259

18 August 2011 Application Accepted

  Published as AU-B-2008242703

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008242710-Bifurcation stent and method of positioning in a body lumen

2008242699-Service regulator with improved boost performance